Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Formycon, GE Healthcare, J&J, Kalvista, Modalis.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Atricure, Elucid, Qnovia, Relu, Surmodics.
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Antengene, Biocity, Catalyst, Hutchmed, Innovent, Junshi, Leo Pharma, Merco & Co., Nxera, Sanofi, Vifor.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Beigene, Biomea Fusion, Crinetics, Formycon, Fresenius Kabi, Regeneron, Sanofi, Xbrane.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Accelerate Diagnostics, GE Healthcare, Pi-Cardia, Siemens Healthineers .
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Ani, Astrazeneca, Bayer, Biocity, Enterprise, Eydisbio, Innovent, Pharming, PTC, Vertex.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Boston Scientific, Establishment Labs, Qiagen.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Amarex, Amgen, Eli Lilly, Elixirgen, Heron, Junshi, Merck.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Arcutis, Aurinia, Capricor, Catalyst, Dydo, GSK, Hutchmed, Nxera, Santhera, Takeda, Vifor, Zeria.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Human in Motion Robotics.